Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors.

PURPOSE Photodynamic therapy is effective in the treatment of superficial urothelial cancer of the bladder. We report our experience with photodynamic therapy for the treatment of upper urinary tract transitional cell carcinoma. MATERIALS AND METHODS Photodynamic therapy after oral administration of 5-aminolevulinic acid was performed in 4 patients with widespread superficial papillary tumors of the upper urinary tract. RESULTS Complete remission occurred in 2 patients who remained free of local recurrence at 7 and 17 months of followup. In the other 2 patients residual tiny papillary tumors were found in the distal ureter after photodynamic therapy. These tumors were coagulated with neodymium:YAG laser irradiation. Both patients are disease-free at 24-month followup. CONCLUSIONS Photodynamic therapy with 5-aminolevulinic acid is a minimally invasive approach for organ preserving treatment of multifocal superficial transitional cell carcinoma of the upper urinary tract.

[1]  A. J. MacRobert,et al.  Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. , 1993, British Journal of Cancer.

[2]  H Stepp,et al.  Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias. , 1995, Urologia internationalis.

[3]  E. Bergstralh,et al.  Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. , 1996, Urology.

[4]  Michele T. Cooper,et al.  Cutaneous phototoxic occurrences in patients receiving Photofrin® , 1990, Lasers in surgery and medicine.

[5]  M. de Kock,et al.  Local excision and topical thiotepa in the treatment of transitional cell carcinoma of the renal pelvis: a case report. , 1986, The Journal of urology.

[6]  U. Studer,et al.  Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. , 1989, The Journal of urology.

[7]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[8]  R. Riesenberg,et al.  Photodynamic effects of 5-aminolevulinic acid-induced porphyrin on human bladder carcinoma cells in vitro. , 1996, European journal of cancer.

[9]  T. Wieman,et al.  Complications of whole bladder dihematoporphyrin ether photodynamic therapy. , 1989, The Journal of urology.

[10]  J. Eastham,et al.  Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. , 1993, The Journal of urology.

[11]  R Baumgartner,et al.  Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. , 1994, Urology.

[12]  M. Soloway,et al.  Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma. , 1990, The Journal of urology.

[13]  A. Hofstetter,et al.  Laser treatment of ureteral tumors. , 1989, The Journal of urology.

[14]  R Baumgartner,et al.  Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.

[15]  J. Mcleod,et al.  Autonomic Dysfunction in Peripheral Nerve Disease , 1993, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.